spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Cordis  

 HSMN NewsFeed - 16 Oct 2023
Cordis issues statement on the CMS announcement to expand coverage of carotid stenting
Devices Interventional Reimbursement
 HSMN NewsFeed - 2 Oct 2023
MedAlliance Acquired by Cordis for up to USD 1.135 Billion
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 14 Sep 2023
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
Devices Interventional Cardiology
 HSMN NewsFeed - 31 May 2023
Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
Devices Interventional
 HSMN NewsFeed - 14 Mar 2023
Over 1,000 Patients Enrolled in Landmark SELUTION DeNovo Study
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Jan 2023
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Jan 2023
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 Nov 2022
Cordis promotes Alan Tsai as GM Greater China
Devices Interventional Personnel
 HSMN NewsFeed - 25 Oct 2022
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 18 Oct 2022
Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology
Devices Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 18 Oct 2022
MedAlliance to be Acquired by Cordis
Devices Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 14 Jun 2022
Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable Inferior Vena Cava (IVC) Filter
Devices Venture Capital
 HSMN NewsFeed - 10 Mar 2022
S.M.A.R.T. RADIANZ(TM) Vascular Stent System Approved for Transradial Use in the U.S.
Devices Interventional FDA
 HSMN NewsFeed - 2 Nov 2021
Cordis Names Muscari President of the Americas
Devices Interventional Personnel
 HSMN NewsFeed - 15 Mar 2021
ViewRay Announces Departure of Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 12 Mar 2021
Cardinal Health Signs Definitive Agreement to Sell its Cordis Business to Hellman & Friedman
Devices Cardiology Acquisitions
 HSMN NewsFeed - 9 Jun 2020
Saluda Medical Appoints Jim Schuermann as President and Robert Gaffney as Chief Operating Officer
Devices Neurology Personnel
 HSMN NewsFeed - 6 Aug 2019
CeloNova Announces Appointment of New President and CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 11 May 2018
Cerus Endovascular Promotes Stephen Griffin, PhD, to President
Devices Interventional Radiology Neurology Personnel
 HSMN NewsFeed - 13 Feb 2018
Aptinyx Appoints Ashish Khanna Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Nov 2017
Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 11 Oct 2017
Silk Road Medical Appoints World Class Stroke Prevention Champion to Serve as Vice President, Medical Affairs and Professional Education
Devices Neurology Personnel
 HSMN NewsFeed - 14 Sep 2017
Haemonetics Appoints David J. Wilson Plasma Business Unit President
Devices Personnel
 HSMN NewsFeed - 7 Mar 2017
ViCentra Announces New Chairman of the Board
Devices Drug Delivery Personnel
 HSMN NewsFeed - 20 Dec 2016
TriReme Medical Signs Agreement With HealthTrust To Broaden Hospital Access To Chocolate(R) And Glider(TM) Product Lines
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 2 Nov 2016
Cardinal Health Announces New Strategic Distribution Agreements to Expand Cordis' Cardiovascular Product Offerings in Asia Pacific
Devices Cardiology Distribution
 HSMN NewsFeed - 7 Sep 2016
Marinus Appoints Seth H.Z. Fischer to its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Jul 2016
QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 7 Jul 2016
QT Vascular Receives CE Mark Clearance for Chocolate Heart(TM), a Novel Drug-Coated Coronary Balloon
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 Jan 2016
QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Sep 2015
QT Vascular Announces Positive Outcome in Spectranetics/AngioScore Patent Trial
Devices Interventional Litigation
 HSMN NewsFeed - 5 Jun 2015
Cardinal Health To Acquire The Harvard Drug Group For $1.115 Billion
Biopharmaceuticals Devices Distribution Acquisitions
 HSMN NewsFeed - 19 May 2015
FDA Grants Premarket Approval for Silk Road Medical's ENROUTE(R) Transcarotid Stent System
Devices Interventional FDA
 HSMN NewsFeed - 10 Mar 2015
Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 19 Nov 2014
Cordis Corporation Leads With Strong Podium Presence At VEITH 2014 With First-Ever Presentation Of Three-Year INCRAFT(R) System Data
Devices Interventional
 HSMN NewsFeed - 10 Sep 2014
Cordis Corporation Launches INCRAFT(R) AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms (AAA)
Devices Interventional Product Launch
 HSMN NewsFeed - 14 Jul 2014
Intact Vascular, Inc. Hires Bruce Shook as President and Chief Executive Officer
Devices Interventional Personnel
 HSMN NewsFeed - 21 Feb 2014
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 28 Jan 2014
Two-Year Data from INNOVATION Trial on INCRAFT(R) AAA Stent Graft System Continues to Demonstrate Safety and Performance in Treatment of Abdominal Aortic Aneurysms
Devices Interventional
 HSMN NewsFeed - 4 Sep 2013
InspireMD Announces New Appointment to the Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 12 Mar 2013
Cordis Acquires Flexible Stenting Solutions, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 8 Nov 2012
S.M.A.R.T.(R) Vascular Stent Systems Receive FDA Approval for Use in SFA
Devices Interventional FDA
 HSMN NewsFeed - 10 Oct 2012
Svelte Medical Systems Announces Appointment of Jack Darby to President and Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 8 Feb 2012
Velomedix Closes New Financing, Strengthens Leadership Team
Devices Cardiology Neurology Venture Capital Personnel
 HSMN NewsFeed - 7 Feb 2012
ETView Medical, Ltd., and NeuroMed Ltd. (NeuroMed), Execute Distribution Agreement
Devices Distribution
 HSMN NewsFeed - 24 Jan 2012
LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 14 Sep 2011
Endosense Names Jan Keltjens President and Chief Executive Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 15 Jun 2011
SurModics Comments on Johnson & Johnson Announcement
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2011
Johnson & Johnson Announces Special Charge Related to Restructuring Plans for Cordis Corporation Subsidiary
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2011
Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2011
Cordis Launches Integrated Solutions for Transradial Care
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2011
Cordis Launching Two New Products at EuroPCR Congress
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Apr 2011
Cameron Health Appoints Ward Dykstra as Vice President of Global Marketing
Devices Cardiology Personnel
 HSMN NewsFeed - 21 Mar 2011
Cordis Demonstrates Commitment to Advancing Therapies for Below-the-Knee Vascular Disease
Devices Interventional
 HSMN NewsFeed - 15 Dec 2010
Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 30 Nov 2010
Cordis Enters Distribution Agreement with Ostial Solutions for the Worldwide Distribution of the OSTIAL PRO Stent Positioning System(TM)
Devices Interventional Distribution
 HSMN NewsFeed - 30 Sep 2010
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2010
Long Term Data Presented at ESC 2010 Further Support the Benefit of The CYPHER(R) Sirolimus Drug-Eluting Stent Compared to The ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgroups
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2010
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Aug 2010
Urologix Announces Election of Christopher R. Barys as Director
Devices Urology Personnel
 HSMN NewsFeed - 6 Jul 2010
Endologix Appoints Todd Abraham Vice President of Operations
Devices Interventional Personnel
 HSMN NewsFeed - 1 Jul 2010
Symmetry Medical Appoints Jose Fernandez Senior Vice President of New Product Development
Devices Orthopaedic Personnel
 HSMN NewsFeed - 17 Jun 2010
Deborah Heart and Lung Center Debuts New Technology
Devices Cardiology Interventional Cardiology
 HSMN NewsFeed - 2 Jun 2010
Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
Devices Neurology Personnel
 HSMN NewsFeed - 27 May 2010
CORDIS Launches ExoSeal(TM) Vascular Closure Device
Devices Interventional
 HSMN NewsFeed - 25 May 2010
NEVO Sirolimus-eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data
Devices Interventional Cardiology
 HSMN NewsFeed - 24 May 2010
IDEV Technologies Names Veteran Healthcare Executive Dennis Donohoe, M.D. Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 20 May 2010
AngioDynamics Appoints Lynda Wallace Senior Vice President of Business Development
Devices Personnel
 HSMN NewsFeed - 9 Apr 2010
First Patients Enrolled in Cordis Trial of New Stent Graft System to Treat Abdominal Aortic Aneurysm
Devices Interventional
 HSMN NewsFeed - 9 Apr 2010
First Patients Enrolled in Cordis Trial of New Stent Graft System to Treat Abdominal Aortic Aneurysm
Devices Interventional
 HSMN NewsFeed - 17 Mar 2010
Caron D'Ambruso Joins SafeStitch as Vice President of Sales and Marketing
Devices Surgery Personnel
 HSMN NewsFeed - 16 Mar 2010
Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the CYPHER(R) Sirolimus Drug-Eluting Stent over the Endeavor(R) Zotarolimus-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Mar 2010
Cordis Unveils Next Generation CoCr Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Feb 2010
Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes
Devices Litigation Interventional Cardiology
 HSMN NewsFeed - 9 Dec 2009
Al Novak Elected Chairman of the Board of OrbusNeich Medical
Devices Interventional Personnel
 HSMN NewsFeed - 29 Sep 2009
SafeStitch Medical, Inc. Appoints Dr. Chao Chen to Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 31 Aug 2009
First Patient Enrolled in CYPRESS, a Dual Antiplatelet Therapy Trial with the CYPHER(R) Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Aug 2009
Stentys appoints Vice President of Sales and Marketing
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 21 Jul 2009
AngioDynamics Appoints Shawn McCarthy Senior Vice President and General Manager of Its Peripheral Vascular Business Unit
Devices Personnel
 HSMN NewsFeed - 27 May 2009
Cytori Completes Enrollment in First Adipose Stem & Regenerative Cell Therapy Trial for Chronic Heart Disease
Regenerative Medicine Cardiology
 HSMN NewsFeed - 19 May 2009
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2009
Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality
Devices Neurology Personnel
 HSMN NewsFeed - 11 May 2009
Jan Keltjens Appointed to Board of Directors of AngioDynamics
Devices Interventional Personnel
 HSMN NewsFeed - 11 May 2009
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Apr 2009
New Clinical Data at ACC09 Show the CYPHER Sirolimus-eluting Coronary Stent Outperformed TAXUS LIBERTE and ENDEAVOR Stents in Key Outcome Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2009
TYRX Announces the Appointment of George D. Landau as Vice President, Business Development
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 26 Mar 2009
Cordis Celebrates 50 Years of Transforming Cardiovascular Care
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2009
Cordis Corporation Announces Head-to-Head Randomized Clinical Trial Comparing the NEVO Sirolimus-Eluting Coronary Stent to the XIENCE Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Mar 2009
CYPHER Sirolimus-eluting Coronary Stent Demonstrates Sustained Benefits Compared to Bare-Metal Stents in Six-Year Randomized Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Feb 2009
CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Now Approved in the European Union for Treatment of Patients With Diabetes
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 Feb 2009
Hospitals, Healthcare Providers to Save with New Premier Drug Eluting Coronary Stents Agreements
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 21 Jan 2009
Jan Keltjens Appointed President & CEO of AngioDynamics
Devices Personnel
 HSMN NewsFeed - 15 Jan 2009
Court of Appeals Overturns 2005 Patent Verdict Against Cordis
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 24 Nov 2008
Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President
Devices Cardiology Personnel
 HSMN NewsFeed - 13 Oct 2008
Cordis Announces New Leadership Positions in Key Business Groups
Devices Cardiology Personnel
 HSMN NewsFeed - 30 Sep 2008
Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 4 Sep 2008
Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2008
First Patient Enrolled in Study Evaluating S.M.A.R.T. (R) Nitinol Self-Expandable Stent System in Leg Disease
Devices Interventional
 HSMN NewsFeed - 28 Aug 2008
The CYPHER(R) Sirolimus-eluting Coronary Stent Outperforms the Taxus(R) Stent in People with Diabetes According to Clinical Data in the Journal of the American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Aug 2008
CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Jul 2008
Vascular Therapies LLC Appoints Samuel M. Liang as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 13 May 2008
State-of-the-Art Cobalt Chromium Bare Metal Stent Now Available in Europe
Devices Interventional Cardiology
 HSMN NewsFeed - 5 May 2008
Cordis Corporation Launches New Peripheral Angioplasty Balloon Catheters
Devices Interventional
 HSMN NewsFeed - 5 May 2008
Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 28 Apr 2008
J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc.
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 7 Apr 2008
Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
Devices Personnel
 HSMN NewsFeed - 2 Apr 2008
Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 31 Mar 2008
Tryton Medical, Inc. Closes $14 Million Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 30 Mar 2008
Three Year Follow-up Data Suggest Better Outcomes Were Maintained with the CYPHER(R) Sirolimus-Eluting Coronary Stent Compared to Brachytherapy in Patients with In-Stent Reblockage
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Mar 2008
Cordis Corporation Receives U.S. Food and Drug Administration Clearance for S.M.A.R.T. Nitinol Stent Transhepatic Biliary System for 120 mm and 150 mm Lengths
Devices Interventional FDA
 HSMN NewsFeed - 6 Mar 2008
InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quality Affairs
Devices Personnel
 HSMN NewsFeed - 15 Feb 2008
Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding
Devices Interventional Neurology Personnel
 HSMN NewsFeed - 14 Feb 2008
BioSphere Medical Names Willard W. Hennemann, Ph.D. Vice President, New Product and Business Development
Devices Personnel
 HSMN NewsFeed - 11 Feb 2008
Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jan 2008
LifeSync Corporation Appoints Nancy McLane as Senior Vice President Operations
Devices Monitoring Personnel
 HSMN NewsFeed - 8 Jan 2008
TyRx Pharma, Inc. Announces the Appointment of Robert M. (Bob) Mattioli as Vice President, Commercial Development
Devices Personnel
 HSMN NewsFeed - 5 Dec 2007
FlowCardia, Inc. Appoints Chris Barys Senior VP, Sales
Devices Interventional Personnel
 HSMN NewsFeed - 8 Nov 2007
New Data Show MIV Therapeutic's Vestasync Drug Eluting Stent Produces Less Fibrinoid and Equivalent Efficacy When Compared to Other Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Nov 2007
Pooled Analysis of Long-Term Data Suggests Cypher(R) Sirolimus-Eluting Coronary Stent Provides Sustained Clinical Benefits in Patients with Coronary Artery Disease Compared to Bare Metal Stents
 HSMN NewsFeed - 31 Oct 2007
Boston Scientific Announces Verdict in Cordis Litigation
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 23 Oct 2007
Adoption of Drug-Eluting Stents Associated with Lower Health Care Costs and Improved Clinical Outcomes
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2007
Next Generation Devices to Treat Clogged Neck Arteries Launched in U.S. and Europe
Devices Interventional
 HSMN NewsFeed - 22 Oct 2007
Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
New Long-Term Data Suggest Clinical Differences in Safety and Efficacy between CYPHER(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Oct 2007
New Study Shows Excellent Outcomes for CYPHER(R) Sirolimus-Eluting Coronary Stent in Treatment of Completely Blocked Coronary Arteries
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2007
Cordis Corporation Announces Clinical Studies and Events at TCT 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Sep 2007
Cordis Corporation Introduces FIRE STAR(TM) Rx PTCA Dilatation Catheter and DURA STAR(TM) Rx PTCA Dilatation Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2007
The CYPHER(R) Sirolimus-Eluting Coronary Stent Outperforms the Taxus Stent in Small Coronary Vessels According to New Clinical Data Analysis Published in the Journal of the American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Sep 2007
Largest Study to Date Finds Drug-Eluting Stents and Bare-Metal Stents Yield Similarly Low Mortality Rates
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2007
Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Sep 2007
Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Sep 2007
Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2007
Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Aug 2007
CryoCath Announces Addition to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 31 Jul 2007
Johnson & Johnson Plans to Improve Overall Cost Structure, While Continuing to Invest in Opportunities for Sustained Profitable Growth
Biopharmaceuticals Devices
 HSMN NewsFeed - 10 Jul 2007
CardioVascular BioTherapeutics Authorized to Initiate Phase II Trial of Angiogenesis Therapy for Severe Coronary Heart Disease
Biopharmaceuticals Devices Drug Delivery Cardiology FDA
 HSMN NewsFeed - 27 Jun 2007
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 14 Jun 2007
Cordis Corporation Resolves Corporate Warning Letter
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Jun 2007
New Balloon Catheter Available Worldwide for Carotid and Renal Angioplasty Procedures
Devices Interventional
 HSMN NewsFeed - 23 May 2007
Cordis Corporation Signs Definitive Agreement with Medinol for Global Distribution of Bare Metal Stents
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 22 May 2007
CYPHER(R) Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 9 May 2007
New Device Granted Humanitarian Exemption to Treat Intracranial Aneurysms
Devices FDA Neurology Interventional
 HSMN NewsFeed - 2 May 2007
FDA Clearance Received for Heart Attack Stem Cell Clinical Trial
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 18 Apr 2007
Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for Peripheral Angioplasty Balloon Catheters
Devices Interventional Distribution
 HSMN NewsFeed - 30 Mar 2007
Cordis Corporation Starts Pivotal Trial for ExoSeal(TM) Vascular Closure Device
Devices Interventional
 HSMN NewsFeed - 27 Mar 2007
CYPHER(R) Sirolimus-eluting Coronary Stent Demonstrates Sustained Benefits Compared to Bare-Metal Stents in Five-Year Randomized Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2007
Two-Year Patient Registry Results Support Safety and Efficacy of CYPHER(R) Sirolimus-Eluting Coronary Stent in 'Real World' Uses
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2007
CYPHER(R) Sirolimus-eluting Coronary Stent Had Similar Results to Bypass Surgery in Long-Term Study of Patients With Multi-Vessel Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Mar 2007
Angiotech appoints Santi Corsaro Vice President, Sales and Marketing OUS
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 20 Mar 2007
Cordis Corporation to Emphasize Commitment to Interventional Cardiology at ACC.07
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Feb 2007
Cordis Corporation Launches Family of REGATTA(TM) Steerable Guidewires
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Feb 2007
New Version of Devices to Treat Clogged Neck Arteries Approved by U.S. Food and Drug Administration
Devices Interventional FDA
 HSMN NewsFeed - 13 Feb 2007
Volcano Corporation Announces Distribution Agreement for Peripheral and Endovascular IVUS Indications in Japan
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 12 Feb 2007
Multiple Articles in the New England Journal of Medicine Confirm On-Label, Long-Term Safety and Efficacy of the CYPHER(R) Sirolimus-Eluting Coronary Stent Compared to Bare Metal Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Feb 2007
Boston Scientific Welcomes New England Journal of Medicine Articles on Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Jan 2007
CryoCath Announces New President and CEO
Devices Cardiology Personnel
 HSMN NewsFeed - 23 Jan 2007
Theragenics(R) Announces Appointment of Chief Medical Director
Devices Personnel
 HSMN NewsFeed - 18 Jan 2007
FDA Approves 18-Month Shelf Life for TAXUS(R) Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 17 Nov 2006
SurModics Provides Additional Information on its License Agreement with Conor Medsystems
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 16 Nov 2006
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 15 Nov 2006
Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER(R) Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Nov 2006
TAXUS Long-Term Data Excels in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Nov 2006
Clinical Studies to be Presented at American Heart Association Scientific Sessions Demonstrate Growing Body of Efficacy and Safety Data for the CYPHER(R) Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Cordis to Study Impact of Contributing Factors to Stent Thrombosis in Expansion of 30,000-Stent Patient Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
New Randomized Clinical Trial Results Show the Cypher(R) Sirolimus-Eluting Coronary Stent Outperformed the Taxus Stent in Long Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Oct 2006
Catherine M. Burzik Named CEO of Kinetic Concepts, Inc. (KCI)
Devices Wound Care Personnel
 HSMN NewsFeed - 12 Oct 2006
David Kandzari, M.D., International Expert in Interventional Cardiology, Named Chief Medical Officer of Cordis Cardiology
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 4 Oct 2006
Data Suggest Different Outcomes Between The CYPHER(R) Sirolimus-Eluting Coronary Stent and the Taxus Stent In 'Real World' Settings and Small Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Sep 2006
U.S. Food and Drug Administration Approves New Medical Devices to Treat Clogged Neck Arteries
Devices Interventional FDA
 HSMN NewsFeed - 21 Sep 2006
Cordis Corporation and Brivant Limited Sign Distribution Agreement for Three Interventional Products
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 13 Sep 2006
Study in New England Journal of Medicine Suggests Heart Attack Patients Fare Better with CYPHER(R) Sirolimus-eluting Coronary Stents Than Bare Metal Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Sep 2006
First Drug-Eluting Stent Approved in Europe for Most Severe Form of Arterial Disease in the Leg
Devices Interventional Regulatory
 HSMN NewsFeed - 6 Sep 2006
Data Suggest the Cypher(R) Sirolimus-Eluting Coronary Stent Provides Sustained Clinical Benefits In Patients With Coronary Artery Disease Compared to Bare Metal Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Jul 2006
Cordis Corporation Acquires Ensure Medical, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 11 Jul 2006
SurModics' Hydrophilic Coating Used on CYPHER SELECT(TM) PLUS
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Jun 2006
Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for New Balloon Dilation Catheter
Devices Distribution Interventional Cardiology
 HSMN NewsFeed - 22 Jun 2006
Cordis Corporation's Third-Generation Coronary Stent Approved for Use in Europe
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 31 May 2006
Cordis Announces Nationwide Introduction of Breakthrough Devices to Treat Artery Blockages in Leg
Devices Interventional
 HSMN NewsFeed - 25 May 2006
Cordis Corporation to Establish New Innovative Research Center in Silicon Valley
Devices Cardiology
 HSMN NewsFeed - 23 May 2006
Campbell Rogers, M.D., International Expert in Interventional Cardiology and Vascular Conditions, Named Chief Technology Officer of Cordis Corporation
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 17 May 2006
Cordis Corporation Submits Pre-Market Approval Supplement for Direct Stenting
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 16 May 2006
Study Suggests Drug-Eluting Stent Type and Vessel Size are Important Predictors of Reblockage in Coronary Artery
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
Physicians Now Have a New Treatment Option for Patients With a Common Vascular Disease Affecting the Legs
Devices Interventional
 HSMN NewsFeed - 16 May 2006
Stereotaxis Announces First Pre-clinical Evaluation of a Magnetically Enabled Injection Catheter
Devices Cardiology Regenerative Medicine
 HSMN NewsFeed - 15 May 2006
Patient Registry to Evaluate Long-Term Safety and Efficacy of Cordis Next Generation Drug-Eluting Coronary Stents in Clinical Practice
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2006
District Court Issues Two Decisions Regarding Patent Litigation Between Cordis Corporation and Boston Scientific
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 May 2006
Cordis Corporation Submits Pre-Market Approval Submission for Reblockage in Coronary Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 8 May 2006
Dr. Julio Palmaz, Inventor of Stent Widely Used in Coronary and Peripheral Disease, Inducted Into National Inventors Hall of Fame
Devices Interventional Cardiology Personnel
Return to NewsFeed  

 Additional items found! 147

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 147 additional stories matching:
Cordis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.